Literature DB >> 18721277

Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians.

J J Brown1, W Ollier, W Thomson, A Bayat.   

Abstract

Dupuytren's disease (DD) is a permanent nodular condition affecting the palms and digits of the hands, leading to progressive shortening and contractures of the digits often resulting in diminished function and severe deformity. DD is thought to be one of the most common hereditary connective tissue disorders in Caucasians. To elucidate further the aetiology of DD, we compared the HLA-DRB1 phenotype frequencies of DD patients (n=67) against the HLA-DRB1 phenotype frequencies observed in a control population (n=537). HLA-DRB1*15 phenotype frequency was higher in DD positive Caucasoids (37.3%) when compared with control data (20.9%) (corrected P=0.029): we conclude that in Caucasoids of European origin, HLA-DRB1*15 is associated with risk of developing DD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721277     DOI: 10.1111/j.1399-0039.2008.01082.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Role of the HLA System in the Pathogenesis of Dupuytren's Disease.

Authors:  Sara McCarty; Farhatullah Syed; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2010-02-09

2.  The incidence of postoperative flare reaction and tissue complications in Dupuytren's disease using tension-free immobilization.

Authors:  Michael Rivlin; Meredith Osterman; Sidney M Jacoby; Terri Skirven; Uzoma Ukomadu; A Lee Osterman
Journal:  Hand (N Y)       Date:  2014-12

Review 3.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  Assessment of potential cross-reactivity of human endogenous matrix metalloproteinases with collagenase Clostridium histolyticum antibodies in human sera obtained from patients with Dupuytren's contracture.

Authors:  Thomas J Edkins; Roland Koller-Eichhorn; Jack A Alhadeff; Ulrich Mayer; Heinrich Faust; Benjamin J Del Tito
Journal:  Clin Vaccine Immunol       Date:  2012-02-22

Review 5.  Dupuytren's: a systems biology disease.

Authors:  Samrina Rehman; Royston Goodacre; Philip J Day; Ardeshir Bayat; Hans V Westerhoff
Journal:  Arthritis Res Ther       Date:  2011-09-12       Impact factor: 5.156

6.  An intractable case of suspected psoriatic arthritis combined with Dupuytren's disease.

Authors:  Wen Quan Ding; Jian Hui Gu
Journal:  Pak J Med Sci       Date:  2015 Jan-Feb       Impact factor: 1.088

7.  Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren's disease.

Authors:  Junghyun Jung; Go Woon Kim; Byungjo Lee; Jong Wha J Joo; Wonhee Jang
Journal:  BMC Med Genomics       Date:  2019-07-11       Impact factor: 3.063

8.  Transethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associations.

Authors:  Frauke Degenhardt; Gabriele Mayr; Mareike Wendorff; Gabrielle Boucher; Eva Ellinghaus; David Ellinghaus; Hesham ElAbd; Elisa Rosati; Matthias Hübenthal; Simonas Juzenas; Shifteh Abedian; Homayon Vahedi; B K Thelma; Suk-Kyun Yang; Byong Duk Ye; Jae Hee Cheon; Lisa Wu Datta; Naser Ebrahim Daryani; Pierre Ellul; Motohiro Esaki; Yuta Fuyuno; Dermot P B McGovern; Talin Haritunians; Myhunghee Hong; Garima Juyal; Eun Suk Jung; Michiaki Kubo; Subra Kugathasan; Tobias L Lenz; Stephen Leslie; Reza Malekzadeh; Vandana Midha; Allan Motyer; Siew C Ng; David T Okou; Soumya Raychaudhuri; John Schembri; Stefan Schreiber; Kyuyoung Song; Ajit Sood; Atsushi Takahashi; Esther A Torres; Junji Umeno; Behrooz Z Alizadeh; Rinse K Weersma; Sunny H Wong; Keiko Yamazaki; Tom H Karlsen; John D Rioux; Steven R Brant; Andre Franke
Journal:  Hum Mol Genet       Date:  2021-04-27       Impact factor: 6.150

9.  Dupuytren's Contracture in Alabama HFE Hemochromatosis Probands.

Authors:  James C Barton; J Clayborn Barton
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.